Intelligence / Healthtech / New Clinical Trials / BeOne Medicines
Clinicaltrial registered29 Oct 2026
BeOne Medicines
29 Oct 2026: Trial registered · A Study of BON-C1393 in Adults With Advanced Solid Tumors. Recorded in the ClinicalTrials.gov (US National Library of Medicine).
- Posted
- 29 Oct 2026
- Title
- A Study of BON-C1393 in Adults With Advanced Solid Tumors
- Conditions
- Solid Tumors, Advanced Solid Tumors
- Phase
- Phase 1
- Study Type
- Interventional
- Status
- Not Yet Recruiting
- Reference
- NCT07904845
What this signal means
A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at BeOne Medicines
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.
Across AOS Research
Other records for BeOne Medicines in our registers.
12 NovBeOne Medicinestrial registered · HealthtechClinical3 NovBeOne Medicinestrial registered · HealthtechClinical27 OctBeOne Medicinestrial registered · HealthtechClinical26 OctBeOne Medicinestrial registered · HealthtechClinical21 OctBeOne Medicinestrial registered · HealthtechClinical
Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.